164 related articles for article (PubMed ID: 27874877)
1. Low-dose radiotherapy for primary cutaneous anaplastic large-cell lymphoma while on low-dose methotrexate.
Cornejo CM; Novoa RA; Krisch RE; Kim EJ
Cutis; 2016 Oct; 98(4):253-256. PubMed ID: 27874877
[TBL] [Abstract][Full Text] [Related]
2. [Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy].
Sumitani R; Harada T; Nakamura M; Mizuguchi M; Oura M; Sogabe K; Maruhashi T; Takahashi M; Fujii S; Nakamura S; Miki H; Kagawa K; Yada M; Matsudate Y; Uehara H; Abe M
Rinsho Ketsueki; 2022; 63(6):536-543. PubMed ID: 35831185
[TBL] [Abstract][Full Text] [Related]
3. Low-dose Methotrexate Treatment for Solitary or Localized Primary Cutaneous Anaplastic Large Cell Lymphoma: A Long-term Follow-up Study.
Park JB; Yang MH; Kwon DI; Seong SH; Jang JY; Suh KS; Jang MS
Acta Derm Venereol; 2020 Feb; 100(4):adv00069. PubMed ID: 31996929
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group.
Melchers RC; Willemze R; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Veraart JCJM; Vermeer MH; Quint KD
Br J Dermatol; 2018 Sep; 179(3):724-731. PubMed ID: 29494757
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Vonderheid EC; Sajjadian A; Kadin ME
J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262
[TBL] [Abstract][Full Text] [Related]
6. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
Kadin ME
Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders.
Kempf W; Kazakov DV; Paredes BE; Laeng HR; Palmedo G; Kutzner H
Dermatology; 2013; 227(4):346-52. PubMed ID: 24246691
[TBL] [Abstract][Full Text] [Related]
8. Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) in the Elderly and the Importance of Sport Activity Training.
Sica A; Vitiello P; Ronchi A; Casale B; Calogero A; Sagnelli E; Costa Nachtigal G; Troiani T; Franco R; Argenziano G; Moscarella E; Sagnelli C
Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32013101
[TBL] [Abstract][Full Text] [Related]
9. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
[TBL] [Abstract][Full Text] [Related]
10. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].
Slotosch CM; Hörster S; Hertl M; Schultz E
Hautarzt; 2010 Jun; 61(6):511-3. PubMed ID: 19536511
[TBL] [Abstract][Full Text] [Related]
11. Case of primary cutaneous anaplastic large cell lymphoma misdiagnosed as squamous cell carcinoma by pseudocarcinomatous hyperplasia.
Hoashi T; Asahara M; Shirakawa N; Mayumi N; Nakayama K; Omori I; Inokuchi K; Sugaya M; Funasaka Y; Saeki H
J Dermatol; 2018 Jun; 45(6):e163-e164. PubMed ID: 29314194
[No Abstract] [Full Text] [Related]
12. Practical Management of CD30⁺ Lymphoproliferative Disorders.
Hughey LC
Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
[TBL] [Abstract][Full Text] [Related]
13. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous CD30+ anaplastic large-cell lymphoma with generalized skin involvement and involvement of one peripheral lymph node, successfully treated with low-dose oral etoposide.
Yamane N; Kato N; Nishimura M; Ito M; Yanagi T; Osawa R
Clin Exp Dermatol; 2009 Jul; 34(5):e56-9. PubMed ID: 19438576
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous anaplastic large-cell lymphoma with 6p25.3 rearrangement exhibits a biphasic histopathologic pattern: Two case reports and literature review.
Xue YN; Wang Z; Sun JF; Chen H
J Cutan Pathol; 2021 Dec; 48(12):1463-1470. PubMed ID: 34164830
[TBL] [Abstract][Full Text] [Related]
16. Lymphomatoid Papulosis and Other Lymphoma-Like Diseases.
Moy A; Sun J; Ma S; Seminario-Vidal L
Dermatol Clin; 2019 Oct; 37(4):471-482. PubMed ID: 31466587
[TBL] [Abstract][Full Text] [Related]
17. Acitretin combined with NB-UVB in the treatment of cutaneous CD30-positive anaplastic large cell lymphoma.
Xu H; Liu Q; Li YM; Ma H; Hu HM
Dermatol Ther; 2019 Mar; 32(2):e12834. PubMed ID: 30659723
[TBL] [Abstract][Full Text] [Related]
18. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
[TBL] [Abstract][Full Text] [Related]
19. [Primary cutaneous anaplastic CD30+ large cell lymphoma].
Marrero-Calvo MD; Rodríguez-Serna M; Castejón-Calvete P; Peláez-Malagón S
Actas Dermosifiliogr; 2007 Apr; 98(3):194-7. PubMed ID: 17504705
[TBL] [Abstract][Full Text] [Related]
20. Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma.
Gratzinger D; Million L; Kim YH
Am J Dermatopathol; 2015 Oct; 37(10):767-70. PubMed ID: 26381026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
